Davis R Ingram

8PUBLICATIONS
118CO-AUTHORS
Molecular targetsSolid tumoursPredictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 21, 2026
Panitumumab-Based EGFR Blockade in SMARCB1-Deficient Renal Medullary Carcinoma: Preclinical Basis and Prospective Clinical Activity.

|Apr 20, 2026
Phase II Trial of Ixazomib Combined with Gemcitabine and Doxorubicin in Patients with SMARCB1-Deficient Renal Medullary Carcinoma.

|Jan 15, 2026
Validation of a Seven-Gene Predictive SIGNature for the Efficacy of Immuno-Oncology PD-1 Inhibitors in Patients with Sarcoma.

David S Moura, Jesus Lopez-Marti, Hussein Tawbi

|Oct 03, 2025
EWS::WT1 Isoform-Dependent Regulation of Neogenes in Desmoplastic Small Round Cell Tumors.

Danh D Truong, Justin W Magrath, Kevin Murgas

|Jan 21, 2025
CA-125 as a Biomarker in Renal Medullary Carcinoma: Integrated Molecular Profiling, Functional Characterization, and Prospective Clinical Validation.

Sandra L Grimm, Menuka Karki, Kyle A Blum

|Apr 01, 2024
Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient Leiomyosarcomas.

Michael S Nakazawa, Ian M Silverman, Victoria Rimkunas

Pageof 2

Frequent Collaborators

7 joint publications

Alexander Lazar

5 joint publications

Wei-Lien Wang

5 joint publications

Khalida Wani

3 joint publications

Menuka Karki